BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhao Y, Liu G, Kwok S, Jones BR, Liu J, Marchisin D, Joyce PE, Peterson J, Shen JX. Highly selective and sensitive measurement of active forms of FGF21 using novel immunocapture enrichment with LC–MS/MS. Bioanalysis 2018;10:23-33. [DOI: 10.4155/bio-2017-0208] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Zhao Y, Gu H, Zeng J. Opportunities and challenges for hybrid immunoaffinity LC-MS approach for quantitative analysis of protein biomarkers. Future Sci OA 2018;4:FSO281. [PMID: 29568570 DOI: 10.4155/fsoa-2017-0148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
2 Kapitanov GI, Chabot JR, Narula J, Roy M, Neubert H, Palandra J, Farrokhi V, Johnson JS, Webster R, Jones HM. A Mechanistic Site-Of-Action Model: A Tool for Informing Right Target, Right Compound, And Right Dose for Therapeutic Antagonistic Antibody Programs. Front Bioinform 2021;1:731340. [DOI: 10.3389/fbinf.2021.731340] [Reference Citation Analysis]
3 Zhao Y, Gu H, Zheng N, Zeng J. Critical considerations for immunocapture enrichment LC–MS bioanalysis of protein therapeutics and biomarkers. Bioanalysis 2018;10:987-95. [DOI: 10.4155/bio-2018-0062] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
4 Neubert H, Shuford CM, Olah TV, Garofolo F, Schultz GA, Jones BR, Amaravadi L, Laterza OF, Xu K, Ackermann BL. Protein Biomarker Quantification by Immunoaffinity Liquid Chromatography–Tandem Mass Spectrometry: Current State and Future Vision. Clinical Chemistry 2020;66:282-301. [DOI: 10.1093/clinchem/hvz022] [Cited by in Crossref: 19] [Cited by in F6Publishing: 22] [Article Influence: 9.5] [Reference Citation Analysis]